Pathological Assessment of Discordant Cases for Molecular (Blueprint and Mammaprint) Vs Clinical Subtypes for Breast Cancer, Among 6,694 Patients from the Eortc 10041/Big 3-04 (Mindact) Trial
AuthID
P-00G-D2V
P-00G-D2V